BofA Lowers Stryker's Price Target Amid Concerns Over Medtech Sector Outlook

Bank of America has reduced its price target on Stryker (SYK) to $380 from $450, citing a softer healthcare utilization environment and increased inflationary pressures. The firm maintains a 'Buy' rating but expresses caution over the medtech sector's growth potential in 2027.

By Sajjl Nooranne Mon, June 22, 2026 at 4:10 PM GMT+3 2 min read · Yahoo Finance · June 22, 2026, 13:10 UTC

BofA Lowers Stryker's Price Target Amid Concerns Over Medtech Sector Outlook

Tickers: $SYK

Topics: medical technology price target change stock analysis

Read the full article at Yahoo Finance

More World news

Nebius Group Reports Massive Q3 2026 Revenue Growth Driven by AI Cloud Expansion Motley Fool · November 12, 2026, 17:29 UTC
Reagan Institute Launches Society of Fellows to Support Early Career Scholars PR Newswire · November 12, 2026, 17:32 UTC
Global Asset Management Group Signs LOI for $100 Million Affordable Housing Portfolio in Washington, D.C. PR Newswire · November 12, 2026, 17:30 UTC
U.S. Air Conditioner and Heat Pump Shipments Increase 27.3% in September Seeking Alpha · November 12, 2026, 17:27 UTC
Nvidia CEO Jensen Huang Resigns Amid Intelligence Probe Seeking Alpha · November 12, 2026, 17:27 UTC
Oklo and Centrus Energy Sign Multi-Year HALEU Fuel Supply Agreements for Ohio Nuclear Campus Seeking Alpha · November 12, 2026, 17:28 UTC
IRS Announces Increased 401(k) Contribution Limits for 2027 CNBC · November 12, 2026, 17:23 UTC
Bit Digital Announces $865 Million Contract and Commencement of 40MW Billing Seeking Alpha · November 12, 2026, 17:20 UTC
Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC